Study reveals that an 11-week, very-low-calorie ketogenic diet significantly reduces body fat and improves glucose metabolism in obese individuals, while also lowering oxidative stress markers,
Patients with a prescription for an opioid use disorder medication may have a tough time getting it filled if their pharmacy is in a community
Systematic review found that Universal Free School Meal (UFSM) programs in the U.S. are linked to increased meal participation, reduced obesity, and fewer school suspensions,
Brain-computer interfaces are still years, and several FDA approvals, away from being available on the market. Even though industry leaders tout their eventual use for
In recent years, the potential of psychedelic drugs in treating mental health disorders like substance use disorder, PTSD, and depression has garnered increasing attention. Numerous
IGNYTE-3 tests the efficacy of RP1 against melanoma when other treatments have failed Replimune has announced the first patient in the Phase III melanoma trial
Psychedelic clinical studies have become a cornerstone in the evolving landscape of mental health treatment. With conditions like depression, PTSD, and anxiety reaching alarming prevalence,
The Food and Drug Administration on Wednesday approved a new treatment for primary biliary cholangitis, an autoimmune liver disease mainly affecting women that causes decreased
What You Should Know: –Levels, a software company that shows you how food affects your health, today announced a $10 million Series A Extension to
What You Should Know: – Fair Square Medicare, a technology company building the next generation of software solutions for Medicare companies, today unveiled Vox, a groundbreaking